From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

CyanConnode – interims, was the fundraising to enhance growth and operational capabilities or mainly to keep the lights on for a bit longer?

By Steve Moore | Friday 8 November 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Most recently writing on company describing itself as “a world leader in narrowband radio frequency mesh networks” CyanConnode (CYAN), in September I questioned is it funding to further enhance its growth and operational capabilities or mainly to help keep the lights on for a bit longer? It has now announced results for its half-year ended 30th September 2024 including emphasising that its “order book has demonstrated strong growth, more than doubling during this period from 6.3 million units at the start of the year to 13.1 million units… remain confident in meeting market expectations for FY”, but why then a current 9.5% lower share price response to 10.525p?

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 03:15:32